Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Feb;59(2):247–250. doi: 10.1038/bjc.1989.50

Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.

E Kjellén 1, J Wennerberg 1, R Pero 1
PMCID: PMC2247013  PMID: 2930689

Abstract

The chromatin-bound enzyme adenosine diphosphate ribosyl transferase is activated by DNA-damaging agents. Substances that inhibit the enzyme, such as benzamide analogues, are known to increase the cytotoxicity of ionising radiation and cytotoxic drugs. The purpose of the present study was to investigate whether the anti-emetic drug metoclopramide, a benzamide derivative (4-amino-N-2-(diethylaminoethyl)-5-chloro-2-methoxybenzamide; MCA), potentiates the effect of cisplatin (cis-diammine-dichloroplatinum; CDDP) on squamous cell carcinoma (SCC). For that purpose human SCC of the head and neck (i.e. tumour line AB and EH) xenografted to nude mice were used. Two administration schedules were tested: (a) MCA (2.0 mg kg-1 i.p.) one hour before CDDP (7.5 mg kg-1 i.p.); and (b) MCA (3 x 2.0 mg kg-1) given concomitant to, 24 and 48 hours after CDDP (7.5 mg kg-1) administration. Treatment efficacies were compared using the area under the growth curves (AUC), tumour volumes and specific growth delay (SGD). There was no mortality and no weight loss of significance in any treatment group. MCA alone did not induce any significant reduction in AUC, tumour volume or SGD with either treatment schedule. CDDP alone gave a significant reduction of tumour growth in tumour line AB but not in tumour line EH. In schedule (a) the addition of MCA did not give any additive effect. However, in schedule (b), for both tumour lines, MCA enhanced the effect of CDDP by significantly reducing the AUC (AB: P less than 0.0001; EH: P less than 0.001) and increasing SGD (AB: P less than 0.012; EH: P less than 0.001) when compared to the tumours given CDDP alone. These effects were observed at a MCA dose currently being administered to humans.

Full text

PDF
247

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bateman D. N., Kahn C., Davies D. S. The pharmacokinetics of metoclopramide in man with observations in the dog. Br J Clin Pharmacol. 1980 Apr;9(4):371–377. doi: 10.1111/j.1365-2125.1980.tb01064.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ben-Hur E. Involvement of poly (ADP-ribose) in the radiation response of mammalian cells. Int J Radiat Biol Relat Stud Phys Chem Med. 1984 Dec;46(6):659–671. doi: 10.1080/09553008414551891. [DOI] [PubMed] [Google Scholar]
  3. Berger N. A. Cancer chemotherapy: new strategies for success. J Clin Invest. 1986 Nov;78(5):1131–1135. doi: 10.1172/JCI112692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berman R., Steel G. G. Induced and inherent resistance to alkylating agents in human small-cell bronchial carcinoma xenografts. Br J Cancer. 1984 Apr;49(4):431–436. doi: 10.1038/bjc.1984.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fodstad O., Aass N., Pihl A. Assessment of tumour growth and of response to chemotherapy of human melanomas in athymic, nude mice. Br J Cancer Suppl. 1980 Apr;4:146–149. [PMC free article] [PubMed] [Google Scholar]
  6. Fujita M., Hayata S., Taguchi T. Relationship of chemotherapy on human cancer xenografts in nude mice to clinical response in donor patient. J Surg Oncol. 1980;15(3):211–219. doi: 10.1002/jso.2930150304. [DOI] [PubMed] [Google Scholar]
  7. George A. M., Lunec J., Cramp W. A., Brennan S., Lewis P. D., Whish W. J. The effects of benzamide ADP-ribosyl transferase inhibitors on cell survival and DNA strand-break repair in irradiated mammalian cells. Int J Radiat Biol Relat Stud Phys Chem Med. 1986 May;49(5):783–798. doi: 10.1080/09553008514552991. [DOI] [PubMed] [Google Scholar]
  8. Giovanella B. C., Stehlin J. S., Jr, Shepard R. C., Williams L. J., Jr Correlation between response to chemotherapy of human tumors in patients and in nude mice. Cancer. 1983 Oct 1;52(7):1146–1152. doi: 10.1002/1097-0142(19831001)52:7<1146::aid-cncr2820520704>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  9. Gralla R. J., Itri L. M., Pisko S. E., Squillante A. E., Kelsen D. P., Braun D. W., Jr, Bordin L. A., Braun T. J., Young C. W. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med. 1981 Oct 15;305(16):905–909. doi: 10.1056/NEJM198110153051601. [DOI] [PubMed] [Google Scholar]
  10. Horsman M. R., Brown D. M., Lemmon M. J., Brown J. M., Lee W. W. Preferential tumor radiosensitization by analogs of nicotinamide and benzamide. Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1307–1310. doi: 10.1016/0360-3016(86)90160-4. [DOI] [PubMed] [Google Scholar]
  11. Jacobs J. R., Kish J., Ensley J. F., Ahmad K., Weaver A., Crissman J., Al-Sarraf M. Combined modality therapy utilizing a cisplatin combination for effective chemotherapy in patients with previously untreated head and neck cancer. Am J Surg. 1986 Oct;152(4):451–455. doi: 10.1016/0002-9610(86)90323-5. [DOI] [PubMed] [Google Scholar]
  12. Kjellén E., Pero R. W., Cameron R., Ranstam J. Radiosensitizing effects of nicotinamide on a C3H mouse mammary adenocarcinoma. A study on per os drug administration. Acta Radiol Oncol. 1986 Jul-Dec;25(4-6):281–284. doi: 10.3109/02841868609136419. [DOI] [PubMed] [Google Scholar]
  13. Lesser M. L., Braun H. I., Helson L. Statistical methods for measuring and comparing treatment efficacies: applications to nude mice experimentation. Exp Cell Biol. 1980;48(2):126–137. doi: 10.1159/000162981. [DOI] [PubMed] [Google Scholar]
  14. Morton R. P., Rugman F., Dorman E. B., Stoney P. J., Wilson J. A., McCormick M., Veevers A., Stell P. M. Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trial. Cancer Chemother Pharmacol. 1985;15(3):283–289. doi: 10.1007/BF00263902. [DOI] [PubMed] [Google Scholar]
  15. Nduka N., Skidmore C. J., Shall S. The enhancement of cytotoxicity of N-methyl-N-nitrosourea and of gamma-radiation by inhibitors of poly(ADP-ribose) polymerase. Eur J Biochem. 1980 Apr;105(3):525–530. doi: 10.1111/j.1432-1033.1980.tb04528.x. [DOI] [PubMed] [Google Scholar]
  16. Osieka R., Houchens D. P., Goldin A., Johnson R. K. Chemotherapy of human colon cancer xenografts in athymic nude mice. Cancer. 1977 Nov;40(5 Suppl):2640–2650. doi: 10.1002/1097-0142(197711)40:5+<2640::aid-cncr2820400938>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  17. Rosenberg B., VanCamp L., Trosko J. E., Mansour V. H. Platinum compounds: a new class of potent antitumour agents. Nature. 1969 Apr 26;222(5191):385–386. doi: 10.1038/222385a0. [DOI] [PubMed] [Google Scholar]
  18. Shorthouse A. J., Peckham M. J., Smyth J. F., Steel G. G. The therapeutic response of bronchial carcinoma xenografts: a direct patient-xenograft comparison. Br J Cancer Suppl. 1980 Apr;4:142–145. [PMC free article] [PubMed] [Google Scholar]
  19. Sims J. L., Sikorski G. W., Catino D. M., Berger S. J., Berger N. A. Poly(adenosinediphosphoribose) polymerase inhibitors stimulate unscheduled deoxyribonucleic acid synthesis in normal human lymphocytes. Biochemistry. 1982 Apr 13;21(8):1813–1821. doi: 10.1021/bi00537a017. [DOI] [PubMed] [Google Scholar]
  20. Skidmore C. J., Davies M. I., Goodwin P. M., Halldorsson H., Lewis P. J., Shall S., Zia'ee A. A. The involvement of poly(ADP-ribose) polymerase in the degradation of NAD caused by gamma-radiation and N-methyl-N-nitrosourea. Eur J Biochem. 1979 Nov 1;101(1):135–142. doi: 10.1111/j.1432-1033.1979.tb04225.x. [DOI] [PubMed] [Google Scholar]
  21. Smulson M. E., Schein P., Mullins D. W., Jr, Sudhakar S. A putative role for nicotinamide adenine dinucleotide-promoted nuclear protein modification in the antitumor activity of N-methyl-N-nitrosourea. Cancer Res. 1977 Sep;37(9):3006–3012. [PubMed] [Google Scholar]
  22. Spang-Thomsen M., Nielsen A., Visfeldt J. Growth curves of three human malignant tumors transplanted to nude mice. Exp Cell Biol. 1980;48(2):138–154. doi: 10.1159/000162982. [DOI] [PubMed] [Google Scholar]
  23. Thraves P., Mossman K. L., Brennan T., Dritschilo A. Radiosensitization of human fibroblasts by 3-aminobenzamide: an inhibitor of poly(ADP-ribosylation). Radiat Res. 1985 Nov;104(2 Pt 1):119–127. [PubMed] [Google Scholar]
  24. Tropé C., Danneskiold-Samsøe P., Hauksson A. High-dose metoclopramide in the treatment of cis-platinum induced emesis. A dose-finding study. Neoplasma. 1985;32(4):507–512. [PubMed] [Google Scholar]
  25. Vermorken J. B., van der Vijgh W. J., Klein I., Hart A. A., Gall H. E., Pinedo H. M. Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin. Cancer Treat Rep. 1984 Mar;68(3):505–513. [PubMed] [Google Scholar]
  26. Ward J. F. Mechanisms of DNA repair and their potential modification for radiotherapy. Int J Radiat Oncol Biol Phys. 1986 Jul;12(7):1027–1032. doi: 10.1016/0360-3016(86)90220-8. [DOI] [PubMed] [Google Scholar]
  27. Warenius H. M., Freedman L. S., Bleehen N. M. The response of a human tumour xenograft to chemotherapy: intrinsic variation between tumours and its significance in planning experiments. Br J Cancer Suppl. 1980 Apr;4:128–132. [PMC free article] [PubMed] [Google Scholar]
  28. Wennerberg J., Alm P., Biörklund A., Killander D., Långström E., Tropé C. Cell cycle perturbations in heterotransplanted squamous-cell carcinoma of the head and neck after mitomycin C and cisplatin treatment. Int J Cancer. 1984 Feb 15;33(2):213–222. doi: 10.1002/ijc.2910330209. [DOI] [PubMed] [Google Scholar]
  29. Wennerberg J., Biörklund A., Tropé C. The effect of cisplatin and fluorouracil on xenografted human squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1988 Feb;114(2):162–167. doi: 10.1001/archotol.1988.01860140060022. [DOI] [PubMed] [Google Scholar]
  30. Wennerberg J. Changes in growth pattern of human squamous-cell carcinomas of the head and neck during serial passages in nude mice. Int J Cancer. 1984 Feb 15;33(2):245–250. doi: 10.1002/ijc.2910330213. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES